Literature DB >> 4861322

Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.

W Chin, P G Contacos, G R Coatney, M H Jeter, E Alpert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4861322     DOI： 10.4269/ajtmh.1967.16.580

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  3 in total

1.  Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt; R N Rossan
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

2.  Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.

Authors:  J R Murphy; S Baqar; J R Davis; D A Herrington; D F Clyde
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

Review 3.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.